European Commission Secures EU Access To Remdesivir For Treatment Of COVID-19
Wednesday, 29 July 2020 ()
The European Commission has signed a contract with the pharmaceutical company Gilead to secure treatment doses of Veklury, the brand name for Remdesivir. Veklury was the first medicine authorized at EU level for treatment of COVID-19.As from early August onwards, and in order to meet immediate needs, batches of Veklury will...